Compare stocks

STRATEC SE, headquartered in Birkenfeld, Germany, specializes in designing and manufacturing fully automated analyzer systems, software, and smart consumables for the in-vitro diagnostics and life sciences sectors. Founded in 1979, the company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on automated analyzer systems for clinical diagnostics and biotechnology clients; the Diatron segment offers systems and consumables for low-throughput hematology and clinical chemistry applications; and the Smart Consumables segment develops polymer-based consumables for diagnostics and medical applications. STRATEC primarily serves as an original equipment manufacturer (OEM), collaborating with diagnostic companies to develop products marketed under their brands. The company's global presence includes facilities in Switzerland, the United States, Romania, Hungary, Austria, and China. Its strategic positioning is reinforced by long-term partnerships with leading in-vitro diagnostics companies and a comprehensive technology portfolio that spans the entire value chain, from design and development to regulatory approval and production. (,)

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.